Keeping adolescents with type 1 diabetes in pediatric diabetes care until at least age 17 may increase the chance that they will have a successful transition to adult care, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
“The transition between pediatric diabetes care and adult diabetes care is known to be fraught with uncertainty,” said lead researcher Joseph Leung, M.D., M.P.H., of the University of British Columbia in Canada. “The risk of dropping out of care is high during this transition.”
The study was designed to determine predictors of successful transition from pediatric to adult diabetes care. The researchers used a health database to identify 3,660 individuals who were diagnosed with type 1 diabetes in childhood and adolescence. They determined each patient’s age at the last pediatric visit, and how much time had elapsed between the last pediatric diabetes visit and the first adult diabetes visit.
They calculated the odds of a “successful transition,” which was defined as seeing an adult diabetes specialist within one year of seeing the pediatric diabetes specialist for the last time. They found teens with type 1 diabetes who remain in pediatric care until at least age 17 are more likely to transition successfully to adult care. Those who leave pediatric care prematurely are less likely to experience a successful transition, they found.
“Adolescents with type 1 diabetes are known to experience a substantial gap when transitioning from pediatric to adult care,” Leung said. “They should be encouraged to stay in pediatric diabetes care until late adolescence before they are transitioned to an adult diabetes specialist.”
About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.
Colleen Williams Associate Director, Communications and Media Relations Phone: (202)-971-3611 [email protected]
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
